Brief: Axovant Announces Partnership With Invitae To Increase Access To Genetic Testing And Accelerate Diagnoses Of Gm1 And Gm2 Gangliosidosis

Sio Gene Therapies

15/04/2020 14:45

April 15 (Reuters) - Axovant Gene Therapies Ltd  AXGT.O :
    * AXOVANT ANNOUNCES PARTNERSHIP WITH INVITAE TO INCREASE
ACCESS TO
GENETIC TESTING AND ACCELERATE DIAGNOSES OF GM1 AND GM2
GANGLIOSIDOSIS
    * AXOVANT GENE THERAPIES - INITIATIVE SUPPORTS
IDENTIFICATION OF
PATIENTS WITH GM1 AND GM2 GANGLIOSIDOSIS WHO ARE CURRENTLY
MISDIAGNOSED OR UNDIAGNOSED

Source text for Eikon:  ID:nGNX8M7gXN 
Further company coverage:  AXGT.O 

 ((Reuters.Briefs@thomsonreuters.com;))